Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An injectable self-adaptive polymer as a drug carrier for the treatment of nontraumatic early-stage osteonecrosis of the femoral head. | Bone Res | 2022 | 35279673 | PubTator, text mining | PubMed |
| Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention. | Int J Mol Sci | 2022 | 35269824 | PubTator, text mining | PubMed |
| Quantitative Proteomics Reveals Molecular Network Driving Stromal Cell Differentiation: Implications for Corneal Wound Healing. | Int J Mol Sci | 2022 | 35269714 | PubTator, text mining | PubMed |
| Natural and Synthetic Agents Targeting Reactive Carbonyl Species against Metabolic Syndrome. | Molecules | 2022 | 35268685 | PubTator, text mining | PubMed |
| Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents. | Mol Genet Metab Rep | 2022 | 35242571 | PubTator, text mining | PubMed |
| CSF proteomic signature predicts progression to Alzheimer's disease dementia. | Alzheimers Dement (N Y) | 2022 | 35229020 | PubTator, text mining | PubMed |
| Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC). | Asian Pac J Cancer Prev | 2022 | 35225452 | PubTator, text mining | PubMed |
| Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. | J Med Chem | 2022 | 35212533 | PubTator, text mining | PubMed |
| Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation. | Cells | 2022 | 35203299 | PubTator, text mining | PubMed |
A Major Intestinal Catabolite of Quercetin Glycosides, 3-Hydroxyphenylacetic Acid, Protects the Hepatocytes from the Acetaldehyde-Induced Cytotoxicity through the Enhancement of the Total Aldehyde Dehydrogenase Activity. | Int J Mol Sci | 2022 | 35163684 | PubTator, text mining | PubMed |
| Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. | Int J Mol Sci | 2022 | 35163279 | PubTator, text mining | PubMed |
| Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside. | Int J Mol Sci | 2022 | 35163235 | PubTator, text mining | PubMed |
| The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases. | Int J Mol Sci | 2022 | 35163178 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| Advances in Regulatory Strategies of Differentiating Stem Cells towards Keratocytes. | Stem Cells Int | 2022 | 35140792 | PubTator, text mining | PubMed |
| Bio-fabrication of stem-cell-incorporated corneal epithelial and stromal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration. | PLoS One | 2022 | 35120168 | PubTator, text mining | PubMed |
| Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms. | Cell Commun Signal | 2022 | 35090496 | PubTator, text mining | PubMed |
| HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer. | Cancers (Basel) | 2022 | 35053572 | PubTator, text mining | PubMed |
| Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway. | Recent Pat Anticancer Drug Discov | 2022 | 35049438 | PubTator, text mining | PubMed |
| Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents. | Exp Eye Res | 2022 | 35032522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=19